Silo Pharma Inc SILO 深 滬
已收盤 07-31 16:00:00 美东时间
4.19
-0.060
-1.41%
華盛通- 最 高4.4144
- 今 開4.30
- 成交量 4542股
- 最 低 4.19
- 昨 收 4.25
- 總市值 472.89万
- 52周最高 15.15
- 市盈率 靜 --
- 換手率 0.40%
- 52周最低 3.315
- 委 比 0.57%
- 總股本 112.86万
- 歷史最高 108.90
- 量 比 0.23
- 振 幅 5.28%
- 歷史最低 3.315
- 每 手 1
- 風險率 2.03%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Silo Pharma Engages Drug-Device Development Partner Resyca To Carry Out Trial To Evaluate Nasal Spray System For Nose-To-Brain Delivery Of SPC-15 To Treat Post-Traumatic Stress Disorder
Silo Pharma (NASDAQ:SILO) ("Silo" or "the Company"), a diversified developmental-stage biopharmaceutical company with a therapeutic focus on addressing underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases, today announced tha...
06-30 04:17
Silo Pharma Confirms Nine‑Month Stability Of SPC‑15 Intranasal Prophylactic, Supporting IND‑Enabling CMC Documentation.
Positive data supports the continued advancement of FDA Investigational New Drug (IND)- enabling development program SARASOTA, FLA., June 23, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (NASDAQ:SILO) ("Silo" or "the Company"), a developmental-stage biopharmaceutical company focused on novel therapeutics an...
06-23 20:19
SILO Pharma Q1 EPS $(0.12) Up From $(0.23) YoY, Sales $18.026K, Same YoY
SILO Pharma (NASDAQ:SILO) reported quarterly losses of $(0.12) per share. This is a 47.83 percent increase over losses of $(0.23) per share from the same period last year. The company reported $18.026 thousand in sales
05-15 04:20
Silo Pharma Launches Ibogaine-Based TBI Drug Initiative, Files Patent Amid Growing Psychedelic Therapy Push
New initiative from Silo Pharma designed to align with federal actions to accelerate mental health innovation using psychedelic medicinesSilo Pharma targets unmet need in a drug market with no FDA-approved therapies that
05-07 20:20
Silo Pharma Highlights Pipeline Strength Amid Rising U.S. Policy Focus On Psychedelic Mental Health Treatments.
SPC-15 Intranasal PTSD Program Aligns with Federal Push to Fast-Track Novel Mental Health TherapiesSARASOTA, Fla., April 20, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ:SILO), a developmental-stage
04-20 18:37
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Lunai Bioworks (NASDAQ:LNAI) stock moved upwards by 47.2% to $0.41 dur...
04-08 01:05
Levi Strauss, Greenbrier And 3 Stocks To Watch Heading Into Tuesday
U.S. stock futures down, investors should watch Levi Strauss, Silo Pharma, Greenbrier, Mach Natural Resources, and Phoenix Education Partners.
04-07 15:21
